Related Experiment Video
Updated: Oct 1, 2026

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
Extracorporal life support for pulmonary hemorrhage in children: a case series
Nikoleta S Kolovos1, Douglas J E Schuerer, Frank W Moler
1Department of Pediatrics, University of Michigan Medical Center, Ann Arbor, USA. kolovos@umich.edu
Insights
Extracorporeal life support (ECMO) can be a life-saving therapy for children with severe respiratory failure due to pulmonary hemorrhage. This study shows all patients treated with ECMO survived and recovered fully.
Area of Science:
- Pediatric critical care medicine
- Cardiopulmonary support technologies
- Respiratory failure management
Background:
- Severe respiratory failure in children can be life-threatening.
- Pulmonary hemorrhage presents a significant challenge in pediatric respiratory care.
- Extracorporeal life support (ECMO) is a potential advanced therapy for refractory respiratory failure.
Purpose of the Study:
- To evaluate the efficacy and outcomes of ECMO in pediatric patients experiencing severe respiratory failure secondary to pulmonary hemorrhage.
- To determine if pulmonary hemorrhage is a contraindication for ECMO therapy.
- To assess the survival and recovery rates of children treated with ECMO for this condition.
Main Methods:
- A retrospective case series design was employed.
- Eight pediatric patients (<19 years) with severe respiratory failure and pulmonary hemorrhage were included.
- Venoarterial or venovenous ECMO was utilized, with detailed monitoring of ventilatory parameters and oxygenation.
Main Results:
- Pulmonary hemorrhage resolved within 24 hours in all patients.
- All patients survived ECMO, decannulation, extubation, and hospital discharge.
- Long-term follow-up (1-10 years) confirmed sustained survival.
Conclusions:
- Extracorporeal life support is a viable and potentially life-sustaining treatment for pediatric severe respiratory failure with pulmonary hemorrhage.
- Pulmonary hemorrhage should not be considered a contraindication for ECMO.
- ECMO offers a critical supportive option for critically ill children with this condition.
Objective:
To examine the use and outcome of extracorporeal life support in children with severe respiratory failure caused by pulmonary hemorrhage.
Design:
Retrospective case series report.
Setting:
Pediatric intensive care unit in a university children's hospital.
Patients:
Eight patients <19 yrs of age who required extracorporeal life support for severe respiratory failure associated with pulmonary hemorrhage.
Interventions:
Venoarterial or venovenous extracorporeal life support.
Measurements:
Ventilatory support parameters and systemic PaO2/FiO2 ratio before extracorporeal life support, time on extracorporeal life support, number of ventilator days, number of intensive care unit days, number of hospital days, continued bleeding on extracorporeal life support, and survival.
Main Results:
All patients had resolution of their pulmonary hemorrhage within 24 hrs. All patients survived to decannulation, extubation, and hospital discharge. All patients are alive, with follow-up times ranging from 1 to 10 yrs.
Conclusions:
Extracorporeal life support is not contraindicated in patients with severe respiratory failure with associated pulmonary hemorrhage and may be a life-sustaining supportive therapy.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism I: Introduction

